跳至主要内容
临床试验/JPRN-UMIN000008469
JPRN-UMIN000008469招募中未知

Effects of beraprost sodium sustained-release tablet on improvement of insulin resistance in patients with type 2 diabetes with obesity in a Double-Blinded, Randomized, Placebo-Controlled, Crossover Trial. - Effects of beraprost sodium sustained-release tablet on improvement of insulin resistance in patients with type 2 diabetes with obesity.

Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases0 个研究点目标入组 40 人开始时间: 2012年7月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with bleeding tendency Patients with Type 1 diabetes or secondary diabetes Patients with severe renal dysfunction Patients with liver dysfunction Patients with a past history if drug hypersensitivity Pregnant women or women with breast-feeding Patients who took prostaglandin derivatives within 3 months Patients whose prescription drugs were changed within 3 months All Patients who is unsuitable for this trial at a physician's discretion

研究者

发起方
Graduate School of Medicine, University of Tokyo Department of Metabolic Diseases

相似试验